“drugs” Archives

in
Entry Author Date Location
Zafgen Restructures, Abandons Obesity Drug Following FDA Meeting 07/19/16 Boston
Eleven Bio’s Eye Disease Drug Set For $22.5M Milestone from Roche 07/08/16 Boston
Alnylam Advances RNAi Drug Results After Two Years of Treatment 07/01/16 Boston
Moderna Gets $200M More, Deepens Merck Ties With New Cancer Pact 06/29/16 Boston
More Job Cuts at Infinity As AbbVie Sends Back Blood Cancer Drug 06/28/16 Boston
Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug 06/27/16 San Diego
Epizyme Touts Early Data From Key Trial Of Blood Cancer Drug 06/19/16 Boston
Struggling Aegerion, QLT to Merge, Change Name to Novelion 06/15/16 Boston
Infinity Closes Research Ops as Blood Cancer Drug Comes Up Short 06/14/16 Boston
Eleven Bio, Still Breathing, Sells Eye Drug to Roche 06/13/16 Boston
Anemia Ups and Downs: Agios Hit On One Drug, Touts Data For Another 06/11/16 Boston
How to Make Healthcare Better? Make It Easy 06/08/16 Boston
Pivoting Again, Catabasis Looks to NASH After Cholesterol Drug Flops 06/07/16 Boston
Biogen’s Nerve Repair Drug Fails MS Study, Shares Fall 06/07/16 Boston
Ocular’s Shares Fall After Eye Treatment Fails Latest Test 06/06/16 Boston
Nektar Therapeutics Gets $20M in Daiichi Deal For Breast Cancer Drug 06/01/16 San Francisco
Two Years After Paying $680M, BioMarin Shelves Duchenne Drug 05/31/16 San Francisco
Amicus Nabs First Approval as EU Gives Green Light to Fabry Drug 05/31/16 New York
Celator Parlays Leukemia Drug Data into $1.5B Buyout From Jazz Pharma 05/31/16 New York
Minerva’s Shares Soar on Early Data for Schizophrenia Drug 05/26/16 Boston
After Failed Trial, Forum CEO Dunsire Leaves, Company’s Fate Unclear 05/25/16 Boston
Spero Rolls up More Antibiotics With Vertex Deal 05/25/16 Boston
Sarepta Saga Drags On as FDA Delays Decision on Duchenne Drug 05/25/16 Boston
Sophiris Streamlines Operations, Weighs Options on Prostate Drug 05/25/16 San Diego
Retooled Selecta Bio Takes Crossover Cash to IPO Queue 05/24/16 Boston
Arbor Pharma Pays $467M for Struggling XenoPort, Restless Legs Drug 05/23/16 San Francisco
Four Years After Neuronex Buyout, Acorda Dumps Epilepsy Drug 05/20/16 New York
CPRIT Marks Midpoint in Texas Agency’s 10-Year Cancer-Fighting Mandate 05/18/16 Texas
Agios, Celgene Jump into Immuno-Oncology in Revamped Alliance 05/17/16 Boston
Pfizer, Moving on From Allergan, Pays $5.2B For Anacor Pharma 05/16/16 San Francisco
Page 4 of 92 « previous page · next page »